Skip to content
10-Q

Quarterly Report

BLUEPRINT MEDICINES CORPORATION

0001558370-24-013960

← back to feed
Filed
Oct 30, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 28, 2024 63.53M sh
Stock Issued Q3 2024 · Sep 30, 2024 0 sh
Stock Issued Q3 2024 · Sep 30, 2024 544.72K sh
Stock Issued Q3 2024 · Sep 30, 2023 0 sh
Stock Issued Q3 2024 · Sep 30, 2023 0 sh
Shares Diluted Q3 2024 · Sep 30, 2024 63.38M sh
Shares Diluted Q3 2024 · Sep 30, 2024 62.61M sh
Shares Diluted Q3 2024 · Sep 30, 2023 60.69M sh
Shares Diluted Q3 2024 · Sep 30, 2023 60.45M sh
Capex Q3 2024 · Sep 30, 2024 $3.7M
Capex Q3 2024 · Sep 30, 2023 $11.39M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$163.22M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$357.92M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $89.36M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $71.29M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $55.97M
Stockholders Equity Q3 2024 · Sep 30, 2024 $313.15M
Stockholders Equity Q3 2024 · Dec 31, 2023 $130.61M
Current Liabilities Q3 2024 · Sep 30, 2024 $257.66M
Current Liabilities Q3 2024 · Dec 31, 2023 $214.92M
Total Liabilities Q3 2024 · Sep 30, 2024 $886.5M
Total Liabilities Q3 2024 · Dec 31, 2023 $918.64M
Current Assets Q3 2024 · Sep 30, 2024 $854.85M
Current Assets Q3 2024 · Dec 31, 2023 $808.39M
Total Assets Q3 2024 · Sep 30, 2024 $1.2B
Total Assets Q3 2024 · Dec 31, 2023 $1.05B
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.89
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.27
Eps Diluted Q3 2024 · Sep 30, 2023 −$2.20
Eps Diluted Q3 2024 · Sep 30, 2023 −$6.55
Eps Basic Q3 2024 · Sep 30, 2024 −$0.89
Eps Basic Q3 2024 · Sep 30, 2024 −$0.27
Eps Basic Q3 2024 · Sep 30, 2023 −$2.20
Eps Basic Q3 2024 · Sep 30, 2023 −$6.55
Sga Expense Q3 2024 · Sep 30, 2024 $89.93M
Sga Expense Q3 2024 · Sep 30, 2024 $262.82M
Sga Expense Q3 2024 · Sep 30, 2023 $70.74M
Sga Expense Q3 2024 · Sep 30, 2023 $215.83M
Rd Expense Q3 2024 · Sep 30, 2024 $85.3M
Rd Expense Q3 2024 · Sep 30, 2024 $257.76M
Rd Expense Q3 2024 · Sep 30, 2023 $110.25M
Rd Expense Q3 2024 · Sep 30, 2023 $330.18M
Net Income Q3 2024 · Sep 30, 2024 −$56.28M
Net Income Q3 2024 · Sep 30, 2024 −$17.13M
Net Income Q3 2024 · Jun 30, 2024 −$49.99M
Net Income Q3 2024 · Mar 31, 2024 $89.14M
Net Income Q3 2024 · Sep 30, 2023 −$133.71M
Net Income Q3 2024 · Sep 30, 2023 −$396.07M
Net Income Q3 2024 · Jun 30, 2023 −$132.79M
Net Income Q3 2024 · Mar 31, 2023 −$129.56M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $1.93M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $12.72M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $2.78M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $8.28M